Skip to content 
Veru Inc., a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome (ARDS) in Florida and internationally. It provides FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections. The company develops enobosarm, a selective androgen receptor modulator for treatment of augment fat loss and to prevent muscle loss in sarcopenic obese and overweight elderly patients; Enobosarm, an oral selective androgen receptor modulator for the treatment of AR+ ER+ HER2- metastatic breast cancer; and sabizabulin, a microtubule disruptor for the treatment of hospitalized patients with viral lung infection at high risk for viral induced ARDS and death. The company was formerly known as The Female Health Company and changed its name to Veru Inc. in July 2017. Veru Inc. was incorporated in 1971 and is headquartered in Miami, Florida. more
| Time Frame | VERU | Sector | S&P500 |
|---|---|---|---|
| 1-Week Return | 11.16% | -1.73% | 0.49% |
| 1-Month Return | -2.35% | 6.45% | 1.02% |
| 3-Month Return | 4.18% | 14.59% | 3.34% |
| 6-Month Return | -23.15% | 5.95% | 7.04% |
| 1-Year Return | -58.5% | 7.5% | 11.68% |
| 3-Year Return | -94.39% | 19.44% | 71.63% |
| 5-Year Return | -98.56% | 35% | 75.56% |
| 10-Year Return | -86.83% | 72.44% | 257.55% |
| Sep '21 | Sep '22 | Sep '23 | Sep '24 | Sep '25 | 5YR TREND | |
|---|---|---|---|---|---|---|
| Total Revenue | 61.26M | 39.35M | 16.30M | 16.89M | - | [{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":64.24,"profit":true},{"date":"2023-09-30","value":26.6,"profit":true},{"date":"2024-09-30","value":27.57,"profit":true},{"date":"2025-09-30","value":"-","profit":true}] |
| Cost of Revenue | 13.33M | 8.76M | 8.73M | 11.03M | 152.10K | [{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":65.73,"profit":true},{"date":"2023-09-30","value":65.49,"profit":true},{"date":"2024-09-30","value":82.75,"profit":true},{"date":"2025-09-30","value":1.14,"profit":true}] |
| Gross Profit | 47.93M | 30.59M | 7.57M | 5.85M | (152.10K) | [{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":63.83,"profit":true},{"date":"2023-09-30","value":15.79,"profit":true},{"date":"2024-09-30","value":12.21,"profit":true},{"date":"2025-09-30","value":-0.32,"profit":false}] |
| Gross Margin | 78.24% | 77.73% | 46.43% | 34.67% | - | [{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":99.36,"profit":true},{"date":"2023-09-30","value":59.34,"profit":true},{"date":"2024-09-30","value":44.31,"profit":true},{"date":"2025-09-30","value":"-","profit":true}] |
| Operating Expenses | 53.36M | 113.81M | 101.35M | 42.77M | 24.75M | [{"date":"2021-09-30","value":46.89,"profit":true},{"date":"2022-09-30","value":100,"profit":true},{"date":"2023-09-30","value":89.05,"profit":true},{"date":"2024-09-30","value":37.58,"profit":true},{"date":"2025-09-30","value":21.75,"profit":true}] |
| Operating Income | 12.97M | (83.22M) | (93.78M) | (36.92M) | (24.75M) | [{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":-641.53,"profit":false},{"date":"2023-09-30","value":-722.92,"profit":false},{"date":"2024-09-30","value":-284.56,"profit":false},{"date":"2025-09-30","value":-190.79,"profit":false}] |
| Total Non-Operating Income/Expense | (13.59M) | (4.68M) | (1.32M) | (768.40K) | - | [{"date":"2021-09-30","value":-1359347500,"profit":false},{"date":"2022-09-30","value":-468486100,"profit":false},{"date":"2023-09-30","value":-131731100,"profit":false},{"date":"2024-09-30","value":-76839800,"profit":false},{"date":"2025-09-30","value":"-","profit":true}] |
| Pre-Tax Income | 4.27M | (83.54M) | (92.67M) | (37.08M) | (15.68M) | [{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":-1958.62,"profit":false},{"date":"2023-09-30","value":-2172.74,"profit":false},{"date":"2024-09-30","value":-869.27,"profit":false},{"date":"2025-09-30","value":-367.65,"profit":false}] |
| Income Taxes | (3.13M) | 236.40K | 480.21K | 725.10K | - | [{"date":"2021-09-30","value":-431.55,"profit":false},{"date":"2022-09-30","value":32.6,"profit":true},{"date":"2023-09-30","value":66.23,"profit":true},{"date":"2024-09-30","value":100,"profit":true},{"date":"2025-09-30","value":"-","profit":true}] |
| Income After Taxes | 7.39M | (83.78M) | (93.15M) | (37.80M) | - | [{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":-1132.97,"profit":false},{"date":"2023-09-30","value":-1259.78,"profit":false},{"date":"2024-09-30","value":-511.22,"profit":false},{"date":"2025-09-30","value":"-","profit":true}] |
| Income From Continuous Operations | 7.39M | (83.78M) | (93.09M) | (37.80M) | (15.68M) | [{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":-1132.97,"profit":false},{"date":"2023-09-30","value":-1258.92,"profit":false},{"date":"2024-09-30","value":-511.22,"profit":false},{"date":"2025-09-30","value":-212.07,"profit":false}] |
| Income From Discontinued Operations | - | - | - | - | - | [{"date":"2021-09-30","value":"-","profit":true},{"date":"2022-09-30","value":"-","profit":true},{"date":"2023-09-30","value":"-","profit":true},{"date":"2024-09-30","value":"-","profit":true},{"date":"2025-09-30","value":"-","profit":true}] |
| Net Income | 7.39M | (83.78M) | (93.15M) | (37.80M) | (22.73M) | [{"date":"2021-09-30","value":100,"profit":true},{"date":"2022-09-30","value":-1132.97,"profit":false},{"date":"2023-09-30","value":-1259.78,"profit":false},{"date":"2024-09-30","value":-511.22,"profit":false},{"date":"2025-09-30","value":-307.35,"profit":false}] |
| EPS (Diluted) | (0.14) | (1.05) | (1.19) | (0.28) | (0.54) | [{"date":"2021-09-30","value":-14,"profit":false},{"date":"2022-09-30","value":-105,"profit":false},{"date":"2023-09-30","value":-119,"profit":false},{"date":"2024-09-30","value":-28.2,"profit":false},{"date":"2025-09-30","value":-54.16,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
| VERU | |
|---|---|
| Current Ratio | 5.16 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
| VERU | |
|---|---|
| ROA (LTM) | -42.92% |
| ROE (LTM) | -60.25% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
| VERU | |
|---|---|
| Debt Ratio Lower is generally better. Negative is bad. | 0.22 |
| Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.78 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
| VERU | |
|---|---|
| Trailing PE | NM |
| Forward PE | 117.65 |
| P/S (TTM) | 3.11 |
| P/B | 1.04 |
| Price/FCF | NM |
| EV/R | 2.65 |
| EV/Ebitda | NM |
| PEG | NM |
Veru Inc (VERU) share price today is $2.4
Yes, Indians can buy shares of Veru Inc (VERU) on Vested. To buy
Yes, you can purchase fractional shares of Veru Inc (VERU) via the Vested app. You can start investing in Veru Inc (VERU) with a minimum investment of $1.
You can invest in shares of Veru Inc (VERU) via Vested in three simple steps:
The 52-week high price of Veru Inc (VERU) is $7.4. The 52-week low price of Veru Inc (VERU) is $2.1.
The price-to-earnings (P/E) ratio of Veru Inc (VERU) is
The price-to-book (P/B) ratio of Veru Inc (VERU) is 1.04
The dividend yield of Veru Inc (VERU) is 0.00%
The market capitalization of Veru Inc (VERU) is $39.97M
The stock symbol (or ticker) of Veru Inc is VERU
Consider the share price of Veru Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Veru Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.
When investing in Veru Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Veru Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.
Rather than merely checking the share price of Veru Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Veru Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.
Link copied 
